BRAF and melanoma: The association of AM404 and GSK126 induced a strong pro-apoptotic effect against three BRAFV600E-mutant melanoma cell lines previously characterized [35] for intrinsic resistance to the BRAF-specific inhibitor PLX4720 (Fig. 6a, b).